Results 151 to 160 of about 33,171 (260)

The role of serum erythropoietin levels in diagnosis and classification of erythrocytosis/polycythemia [PDF]

, 2005
Van Maerken, Tom
core   +1 more source

Advances in polycythemia vera treatment with targeted therapies and clinical trials. [PDF]

Discov Oncol
Hassanien D, AlYafei RA, Metwally OH, Alremawi I, Al-Kaabi AK, Elahtem M, Al-Sayed T, Yassin MA.   +7 more
europepmc   +1 more source

Evaluating inflammatory markers in distinguishing polycythemia Vera from secondary polycythemia: a prospect for novel diagnostic marker. [PDF]

Ann Hematol
Khaksari MN, Oraei Sajjadi K, Arianmanesh F, Ayatollahi H, Boroumand-Noughabi S.   +4 more
europepmc   +1 more source

Mesenchymal stromal cells secretory pattern contributes to oncoinflammatory bone marrow microenvironment in polycythemia vera. [PDF]

Hematol Transfus Cell Ther
Cominal JG, Cacemiro MDC, Berbel GM, Rahimy RML, Rocha GV, Zanette DL, Oliveira MC, Figueiredo-Pontes LL, Malmegrim KCR, Castro FA.   +9 more
europepmc   +1 more source

[Neurologic manifestations of polycythemia vera. Analysis of 24 cases and review of the literature].

, 1990
Corredoira Jc, González López M, Cortés Ja, Gomara García S, Pérez Alvarez R, Casariego Vales B, López Alvarez Mj, García Rodríguez Jf   +7 more
openalex   +1 more source

Current status of hydroxyurea in treatment of polycythemia vera

Weronika Lebowa, Anna Ignatowicz, Julia Ząber, Tomasz Sacha   +3 more
openalex   +2 more sources

Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?

, 2020
Richard T. Silver
openalex   +2 more sources

Emerging Significance and Implications of a Durable Complete Molecular Remission in the Treatment of Polycythemia Vera. [PDF]

Curr Hematol Malig Rep
Duan M, Bose P, Hunter AM, Qin A, Chang L, Li W, Wu D, Rampal RK.   +7 more
europepmc   +1 more source

Washington University Medical Alumni Quarterly, July 1944 [PDF]

, 1944

core   +1 more source

Long-term efficacy and safety of ropeginterferon alfa-2b under its HIDAT regimen for the treatment of polycythemia vera. [PDF]

Blood Adv
Suo S, Fu R, Qin A, Shao Z, Bai J, Zhou H, Xu N, Chen S, Zuo X, Du X, Duan M, Wang L, Li P, Zhang X, Zhang S, Wu D, Zhang J, Xiao Z, Zhang L, Jin J.   +19 more
europepmc   +1 more source